APA (7th ed.) Citation

SGK, Y., F, T., M, T., Y, S., EA, T., K, A., . . . J, M. (2026). GLP-1 receptor agonists for obesity: Eligibility across 99 countries. The lancet. Diabetes & endocrinology, 14(2), 105. https://doi.org/10.1016/S2213-8587(25)00356-0

Chicago Style (17th ed.) Citation

SGK, Yoo, et al. "GLP-1 Receptor Agonists for Obesity: Eligibility Across 99 Countries." The Lancet. Diabetes & Endocrinology 14, no. 2 (2026): 105. https://doi.org/10.1016/S2213-8587(25)00356-0.

MLA (9th ed.) Citation

SGK, Yoo, et al. "GLP-1 Receptor Agonists for Obesity: Eligibility Across 99 Countries." The Lancet. Diabetes & Endocrinology, vol. 14, no. 2, 2026, p. 105, https://doi.org/10.1016/S2213-8587(25)00356-0.